Back
Gartner, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
61
IT
Gartner, Inc.
Last Price:
$247.34
Seasonality Move:
1.67%
Sell
48
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$34.38
Seasonality Move:
6.21%
Buy
61
Gartner, Inc. (IT)
is a Buy
Is Gartner, Inc. a Buy, Sell or Hold?
-
The current Gartner, Inc. [IT] share price is $246.35. The Score for IT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
IT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IT Stock Price Chart
What is Gartner, Inc.'s stock price today?
-
The Gartner, Inc. share price today is $246.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.23The current trend is moderately bearish and RARE is experiencing slight selling pressure.
IT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 63.53 | Buy |
| Chaikin Money Flow: | 1353523 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (226.77 - 235.01) | Buy |
| Bollinger Bands (100): | (221.04 - 277.18) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 61.17 | Buy |
| Chaikin Money Flow: | -296399 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.5 - 35.92) | Buy |
| Bollinger Bands (100): | (28.85 - 34.05) | Buy |
IT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 232.79 | Buy |
| 20-day SMA: | 231.03 | Buy |
| 50-day SMA: | 237.49 | Buy |
| 200-day SMA: | 333.67 | Sell |
| 8-day EMA: | 234.73 | Buy |
| 20-day EMA: | 233.24 | Buy |
| 50-day EMA: | 240.05 | Buy |
| 200-day EMA: | 317.46 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.29 | Sell |
| 20-day SMA: | 34.52 | Buy |
| 50-day SMA: | 33.51 | Buy |
| 200-day SMA: | 33.72 | Buy |
| 8-day EMA: | 35.95 | Buy |
| 20-day EMA: | 34.99 | Buy |
| 50-day EMA: | 33.64 | Buy |
| 200-day EMA: | 34.82 | Buy |
Gartner, Inc. Earnings Growth & IT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $0.68 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
Gartner, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||